Search

Author/Creator De-Oertel, Shampa

1. 537STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96. (December 2014)

Authors:
Creticos, Catherine; Brinson, Cynthia; Mcdonald, Cheryl; Segal-Maurer, Sorana; Brar, Indira; Wade, Barbara; Garner, Will; Porter, Danielle; De-Oertel, Shampa; Weinberg, Amy; Sparrow, Toni
Journal:
Open forum infectious diseases
Issue:
Volume 1(2014)Supplement 1
Page Start:
S21
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. IDDF2018-ABS-0110 Efficacy and safety of SOFOSBUVIR/VELPATASVIR plus RIBAVIRIN for 12 or 24 weeks in genotype 1 or 2 HCV-INFECTED japanese patients with prior treatment failure to daa-based regimens. (June 2018)

Authors:
Izumi, Namiki; Takehara, Tetsuo; Chayama, Kazuaki; Yatsuhashi, Hiroshi; Takaguchi, Koichi; Ide, Tatsuya; Kurosaki, Masayuki; Ueno, Yoshiyuki; Toyoda, Hidenori; Kakizaki, Satoru; Tanaka, Yasuhito; Kawakami, Yoshiiku; Enomoto, Hirayuki; Ikeda, Fusao; Huang, KC; De-Oertel, Shampa; McNabb, Brian L; C...
Journal:
Gut
Issue:
Volume 67(2018)Supplement 2
Page Start:
A99
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. IDDF2018-ABS-0111 Safety and efficacy of treatment with once-daily LEDIPASVIR/SOFOSBUVIR (90/400 MG) for 12 weeks in genotype 1 hcv-infected patients with severe renal impairment. (June 2018)

Authors:
Lawitz, Eric; Landis, Charles S; Maliakkal, Benedict J; Bonacini, Maurizio; Ortiz-Lasanta, Grisell; Zhang, Jie; Mogalian, Erik; De-Oertel, Shampa; Osinusi, Anu O; Brainard, Diana M; McHutchison, John G; Sze Man Yip, Christina; Huang, Hai Cheng; Flamm, Steven L; Gordon, Stuart C; Gane, Edward J
Journal:
Gut
Issue:
Volume 67(2018)Supplement 2
Page Start:
A99
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment. Issue 3 (3rd March 2016)

Authors:
Wilkins, Ed L.; Cohen, Calvin J.; Trottier, Benoit; Esser, Stefan; Smith, Don E.; Haas, Bernhard; Brinson, Cynthia; Garner, Will; Chuck, Susan; Thorpe, David; De-Oertel, Shampa
Journal:
AIDS care
Issue:
Volume 28:Issue 3(2016)
Page Start:
401
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study. (January 2016)

Authors:
van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; Arribas, José R.; Wohl, David A.; Rieger, Armin; Rachlis, Anita; Bloch, Mark; Segal-Maurer, Sorana; Garner, Will; Porter, Danielle; Bosse, Matthew; Piontkowsky, David; Chuck, Susan K.; De-Oertel, Shampa
Journal:
AIDS
Issue:
Volume 30:Number 2(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study. (October 2020)

Authors:
Lawitz, Eric; Landis, Charles S; Flamm, Steven L; Bonacini, Maurizio; Ortiz-Lasanta, Grisell; Huang, Jonathan; Zhang, Jie; Kirby, Brian J; De-Oertel, Shampa; Hyland, Robert H; Osinusi, Anu O; Brainard, Diana M; Robson, Richard; Maliakkal, Benedict J; Gordon, Stuart C; Gane, Edward J
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 5:Number 10(2020)
Page Start:
918
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗